The evolution of treatment options that have significantly improved the quality of life for both Type 1 and Type 2 diabetics. One of the more recent and promising developments is the class of drugs known as GLP-1 receptor agonists, with Ozempic (semaglutide) being a notable example. In this article, I’ll walk you through the history of GLP-1s, provide insights into how Ozempic works, and address common questions and concerns that many—both Type 1 and Type 2 diabetics—have raised.
